Thermo King announced the launch of its Cold Storage Solutions unit intended to meet the unique requirements of global pharmaceutical companies developing COVID-19 vaccines.
Those firms in final-stage clinical trials anticipate they will require strict temperature controls to safeguard their products, down to temperatures as low as minus 70 degrees Celsius. Thermo King’s solutions can enable these companies and their distributors to ensure the efficacy of their products through the entire cold chain, from air transport to marine, rail, trailer, last-mile delivery and at storage points along the way, according to the Swords, Ireland-based company.
“Considering the urgent, global need for a COVID-19 vaccine, the world can’t afford breaks in the cold chain,” Dave Regnery, president of parent company Trane Technologies, said in a release.
Besides launching Cold Storage Solutions, the company noted it has helped customers identify ways to maximize the range of dry ice, which often is used in vaccine transport and storage but has certain limitations. A container using dry ice to keep a product frozen may require re-icing if it sits for an extended length of time or is exposed to extreme ambient weather. — Transport Topics